Brokerage Wealth Management Apps

Hands Off Robo Saver

Knowledge Graph Entities

Dominant · SE Outbound Links ρ=0.588

AI recommendation signal analysis across 63 domains for the Hands Off Robo Saver persona in Brokerage Wealth Management Apps.

Download this report (.xlsx)

63Domains Tracked

Hands Off Robo Saver_persona.report

EntityScore

eToro

60.0

Merrill

49.9

The Vanguard Group

48.1

Royal Bank of Canada

40.0

Wealthfront

35.6

Entitys rankedn = 25

Want a custom AI visibility audit for Brokerage Wealth Management Apps?

This report tracks how AI models and search engines recommend companies across 100 industries. If you want the same analysis run specifically against your own site and competitors, get in touch.

Get in touch →

About This Report

How to use this page

Persona view: this page is scoped to this persona's queries alone.

Use Case

Check your knowledge-graph footprint

Wikidata is the structured knowledge graph behind Wikipedia, search engines, and many AI systems. If the graph does not know a brand, machines have less to anchor an answer on. See which entities carry this segment's topics and brands, and whether its top domains have an entity at all.

How It's Calculated

Where the numbers come from

We scan every Wikidata entity record (labels, descriptions, property values) for this segment's topic phrases and brand hostnames. Entity records are short structured data, so counts run far smaller than article text. Coverage checks which entities claim each domain as an official website.

Overview

What's on this page

Top-entity charts, the full entity table, and a knowledge-graph coverage check for this segment's most LLM-recommended domains.

Segment Totals

Knowledge graph at a glance

How much of the Wikidata knowledge graph touches Hands Off Robo Saver. Entity records are short structured data (labels, descriptions, property values), so these counts run far smaller than Wikipedia article text; what matters is which entities show up, not raw volume.

32K

Entities With Topic Matches

222

Entities Mentioning Brands

32K

Topic Phrase Matches

251

Brand Mentions

Top Domains

Knowledge graph coverage

Whether a Wikidata entity claims each of this segment's most LLM-recommended domains as its official website. A brand without an entity is invisible to systems that navigate the web through the knowledge graph.

18 of 25 top domains for Hands Off Robo Saver have a knowledge-graph entity.

Domain	Knowledge Graph Entity	Wikidata ID

betterment.com	Betterment.com	Q4898585
wealthfront.com	Wealthfront	Q18394708
vanguard.com	Not in the knowledge graph	-
schwab.com	Charles Schwab Corporation	Q1066028
fidelity.com	Fidelity Investments	Q1411292
sofi.com	SoFi	Q17020720
acorns.com	Acorns	Q65072916
m1.com	Not in the knowledge graph	-
ellevest.com	Sallie Krawcheck	Q531496
ally.com	Ally Financial	Q2032800
m1finance.com	M1 Finance	Q65063401
improve.com	Not in the knowledge graph	-
sigfig.com	Wikinvest	Q7999859
merrilledge.com	Merrill	Q334122
wealthsimple.com	Wealthsimple	Q24521620
empower.com	Empower Retirement	Q30634563
robinhood.com	Robinhood	Q18155123
etrade.com	E-Trade	Q2607502
investor.vanguard.com	The Vanguard Group	Q849363
personalcapital.com	Personal Capital	Q21593087
stash.com	Stash Financial Inc.	Q30609598
merrill.com	Not in the knowledge graph	-
elmwealth.com	Not in the knowledge graph	-
vanguardpersonaladvisor.com	Not in the knowledge graph	-
vtsax.com	Not in the knowledge graph	-

Wikidata

Top knowledge-graph entities

The entity records where Hands Off Robo Saver's brands and topics appear. Brand Mentions is the more reliable single ranking here; broadly used phrases can surface large unrelated entities in the topic view. Blended merges the two on a log scale (brand mentions weighted higher, 0 to 100). Bars and entity names link to the record; entities with no label show their Wikidata ID. The table follows the selected view.

Entity	Blended	Brand Mentions	Topic Matches

eToro	60.0	6	0
Merrill	49.9	1	3
The Vanguard Group	48.1	2	1
Royal Bank of Canada	40.0	0	6
Wealthfront	35.6	1	1
Wealthsimple	35.6	1	1
Forbes Best-in-State Top Wealth Management Team	35.6	1	1
JPMorgan Chase	33.9	2	0
Capital One	33.9	2	0
Fidelity Investments	33.9	2	0
Europe This Week	33.9	2	0
Market Watch	33.9	2	0
NerdWallet.com	33.9	2	0
San Francisco Estuary and Watershed Science	33.9	2	0
UCLA Pacific Basin Law Journal	33.9	2	0
MarketWatch	33.9	2	0
The Profit	33.9	2	0
Kraken	33.9	2	0
Merrill Edge	33.9	2	0
Mintos Marketplace	33.9	2	0
Frontiers of biogeography	33.9	2	0
Forbes 30 Under 30	33.9	2	0
Back in the Game	33.9	2	0
Biogeographia	33.9	2	0
Trading 212 UK Limited	33.9	2	0
Forbes ASAP	33.9	2	0
Forbes Best-In-State Wealth Advisor	33.9	2	0
Forbes Top 250 Wealth Advisor	33.9	2	0
Jordan/Zalaznick Advisers Inc.	33.9	2	0
Capital One Auto	33.9	2	0
asset allocation	28.5	0	3
American Century	28.5	0	3
Journal of Real Estate Portfolio Management	28.5	0	3
Jones Lang LaSalle	22.6	0	2
CI Financial	22.6	0	2
Locked-In Retirement Account	22.6	0	2
passive management	22.6	0	2
investment management	22.6	0	2
wealth management	22.6	0	2
Black Creek Investment Management Inc.	22.6	0	2
Validation of a new risk assessment tool: The Brief Risk Questionnaire	22.6	0	2
The antenatal risk questionnaire (ANRQ): acceptability and use for psychosocial risk assessment in the maternity setting	22.6	0	2
Diabetes Risk Assessment in Latinas: Effectiveness of a Brief Diabetes Risk Questionnaire for Detecting Prediabetes in a Community-Based Sample	22.6	0	2
Individual Retirement Account Balances, Contributions, Withdrawals, and Asset Allocation Longitudinal Results 2010–2014: The EBRI IRA Database	22.6	0	2
Public Mood–Driven Asset Allocation: the Importance of Financial Sentiment in Portfolio Management	22.6	0	2
Evaluating health risk tolerance and risk assessment	22.6	0	2
New accounting rules: asset allocation and portfolio management	22.6	0	2
Users evaluate a detailed familial risk questionnaire as valuable and no more time consuming than a simple enquiry in a web-based diabetes risk assessment tool	22.6	0	2
Goethe-Universität Frankfurt am Main Lehrstuhl für Investment Portfolio Management und Alterssicherung	22.6	0	2
Understanding Machine Learning for Diversified Portfolio Construction by Explainable AI	22.6	0	2
SEB Investment Management	22.6	0	2
Wells Fargo Private Bank	22.6	0	2
The Role of Risk Forecast and Risk Tolerance in Portfolio Management: A Case Study of the Chinese Financial Sector	22.6	0	2
Nomkhita Nqweni	22.6	0	2
Investment portfolio management based on the two-step kernel estimator of CVaR	22.6	0	2
An Application of Investment Clock Principle and Tactical Asset Allocation in Portfolio Management: Based on the Adjusted Black-Litterman Model	22.6	0	2
The Impact of Demographic Characteristics and Risk Tolerance on Investors’ Risk Perception and Portfolio Management	22.6	0	2
Optimization of investment portfolio management	22.6	0	2
Optimal Tactical Asset Allocation – Using Recommender Systems in Portfolio Management	22.6	0	2
Outperformance and Tracking: Dynamic Asset Allocation for Active and Passive Portfolio Management	22.6	0	2
Are Passive Index Funds Active Owners? Corporate Governance Consequences of Passive Investing	22.6	0	2
Gender, Risk Tolerance, and False Consensus in Asset Allocation Recommendations	22.6	0	2
A Modern, Behavior-Aware Approach to Asset Allocation and Portfolio Construction	22.6	0	2
Portfolio Construction and Global Asset Allocation: A Practitioner Solution to a Black-Litterman Flaw	22.6	0	2
Retirement Planning and Asset Allocation under Regime Switching Environment	22.6	0	2
PortfolioX	22.6	0	2
AOL	21.4	1	0
AOL Instant Messenger	21.4	1	0
The Wall Street Journal	21.4	1	0
The World's Billionaires	21.4	1	0
Sallie Krawcheck	21.4	1	0
TIAA	21.4	1	0
Forbes	21.4	1	0
Q1023911	21.4	1	0
CNBC	21.4	1	0
The World's Most Powerful People	21.4	1	0
Charles Schwab Corporation	21.4	1	0
Forbes Global 2000	21.4	1	0
Mike Lazaridis	21.4	1	0
Morningstar, Inc.	21.4	1	0
Ally Financial	21.4	1	0
Squawk Box	21.4	1	0
Forbes 400	21.4	1	0
E-Trade	21.4	1	0
J.P. Morgan & Co.	21.4	1	0
Backbase	21.4	1	0
Morgan Creek Entertainment	21.4	1	0
Worldwide Exchange	21.4	1	0
Squawk on the Street	21.4	1	0
Power Lunch	21.4	1	0
Interactive Brokers LLC - ATS	21.4	1	0
Closing Bell	21.4	1	0
Q4261093	21.4	1	0
Ally Bank	21.4	1	0
American Greed	21.4	1	0
Bank of Internet USA	21.4	1	0
Bankrate	21.4	1	0
Betterment.com	21.4	1	0
Capital Connection	21.4	1	0
Clark Howard	21.4	1	0
David Faber	21.4	1	0
Dermatology Online Journal	21.4	1	0
Fast Money	21.4	1	0
Foreign Exchange	21.4	1	0
Investopedia	21.4	1	0
J.P. Morgan in the United Kingdom	21.4	1	0
J.P. Morgan Asset Management	21.4	1	0
Journal of California and Great Basin Anthropology	21.4	1	0
list of acquisitions by AOL	21.4	1	0
Mad Money	21.4	1	0
Nuveen Investments	21.4	1	0
On the Money	21.4	1	0
OpinionJournal.com	21.4	1	0
Rady School of Management	21.4	1	0
SNReview	21.4	1	0
Scottrade	21.4	1	0
Street Signs	21.4	1	0
TD Ameritrade	21.4	1	0
Technology Innovations in Statistics Education	21.4	1	0
The Kudlow Report	21.4	1	0
On the Money	21.4	1	0
Trash Inc: The Secret Life of Garbage	21.4	1	0
Ufahamu	21.4	1	0
Upstart Holdings	21.4	1	0
Wikinvest	21.4	1	0
Forbes' list of the world's highest-paid athletes	21.4	1	0
Morning Call	21.4	1	0
Uri Hezkia Gneezy	21.4	1	0
PaleoBios	21.4	1	0
Berkeley Planning Journal	21.4	1	0
Opolis: an international journal of suburban and metropolitan studies	21.4	1	0
UCLA Journal of Islamic and Near Eastern Law	21.4	1	0
UCLA Entertainment Law Review	21.4	1	0
Issues in Applied Linguistics	21.4	1	0
Critical Planning	21.4	1	0
New German Review	21.4	1	0
Pacific Arts	21.4	1	0
Transit	21.4	1	0
Mester	21.4	1	0
Places Journal	21.4	1	0
Journal of Transnational American Studies	21.4	1	0
Himalayan Linguistics	21.4	1	0
Mohamed Mansour	21.4	1	0
Hesburgh Award	21.4	1	0
Fundrise	21.4	1	0
SoFi	21.4	1	0
Robinhood	21.4	1	0
Secret Lives of the Super Rich	21.4	1	0
Interactive Brokers	21.4	1	0
West Texas Investors Club	21.4	1	0
Personal Capital	21.4	1	0
Forbes	21.4	1	0
International Journal of Comparative Psychology	21.4	1	0
UCLA women's law journal	21.4	1	0
The George Wright forum	21.4	1	0
Papers. Kroeber Anthropological Society	21.4	1	0
California journal of politics and policy	21.4	1	0
Journal of citrus pathology	21.4	1	0
Al Gore	14.2	0	1
Affiliated Managers Group	14.2	0	1
Martin Blessing	14.2	0	1
Mahara	14.2	0	1
National Geographic Society	14.2	0	1
BlackRock	14.2	0	1
Mohamed A. El-Erian	14.2	0	1
Cerberus Capital Management	14.2	0	1
Aberdeen Asset Management	14.2	0	1
Morgan Stanley Wealth Management	14.2	0	1
Standard Life	14.2	0	1
Mary Callahan Erdoes	14.2	0	1
Invesco	14.2	0	1
UNICEF	14.2	0	1
family office	14.2	0	1
BNP Paribas Asset Management	14.2	0	1
buy and hold	14.2	0	1
United States House Homeland Security Subcommittee on Counterterrorism and Intelligence	14.2	0	1
private banking	14.2	0	1
CFA Institute	14.2	0	1
German Federal Institute for Risk Assessment	14.2	0	1
cash management	14.2	0	1
Q1054441	14.2	0	1
risk assessment	14.2	0	1
probabilistic risk assessment	14.2	0	1
Clarity	14.2	0	1
Supply chain risk management	14.2	0	1
Schroders	14.2	0	1
dollar cost averaging	14.2	0	1
Ebenezer Emergency Fund International	14.2	0	1
Fairfax Financial	14.2	0	1
Man Group	14.2	0	1
Financial Markets and Portfolio Management	14.2	0	1
Fortress Investment Group	14.2	0	1
risk matrix	14.2	0	1
ISO 21500	14.2	0	1
total expense ratio	14.2	0	1
Multi-project management	14.2	0	1
Jürg Zeltner	14.2	0	1
Nostro account	14.2	0	1
Schoellerbank	14.2	0	1
project portfolio management	14.2	0	1
PIMCO	14.2	0	1
Planforge	14.2	0	1
Portfolio management	14.2	0	1
technology roadmap	14.2	0	1
health risk assessment	14.2	0	1
managed account	14.2	0	1
Wealth Management Capital Holding	14.2	0	1
Wellington Management Company	14.2	0	1
securities account	14.2	0	1
investment strategy	14.2	0	1
control banding	14.2	0	1
Application Portfolio Management	14.2	0	1
Institute for Risk Assessment Sciences	14.2	0	1
Certified International Wealth Management	14.2	0	1
CNL Lifestyle Properties	14.2	0	1
Farallon Capital	14.2	0	1
Food Additives and Contaminants Part A	14.2	0	1
Indosuez Wealth Management	14.2	0	1
Pharmacovigilance Risk Assessment Committee	14.2	0	1
Sciforma PSNext	14.2	0	1
SOCOTEC	14.2	0	1
Banca Generali Private	14.2	0	1
King Street Capital Management	14.2	0	1
Q3937019	14.2	0	1
Dragon Capital	14.2	0	1
Harris myCFO	14.2	0	1
Ruben Vardanyan	14.2	0	1
rebalancing investments	14.2	0	1
asset management company	14.2	0	1
HeartScore	14.2	0	1
ADEEM Investment and Wealth Management Company	14.2	0	1
AMPC	14.2	0	1
AQR Capital	14.2	0	1
AJ Bell	14.2	0	1
active management	14.2	0	1
AdultVest	14.2	0	1
Osaic	14.2	0	1
Advisorshares	14.2	0	1
Alberta Investment Management Corporation	14.2	0	1
TPG Angelo Gordon	14.2	0	1
Aquila Capital	14.2	0	1
Artemis	14.2	0	1
assessment of suicide risk	14.2	0	1
BAI	14.2	0	1
BNY Mellon Wealth Management Hockey Humanitarian Award	14.2	0	1
BT	14.2	0	1
Baillie Gifford	14.2	0	1
Bessemer Trust	14.2	0	1
BetaShares	14.2	0	1
Bicycle Master Plan	14.2	0	1
Bishopsgate Investment Management Ltd v Maxwell	14.2	0	1
Bishopsgate Investment Management Ltd v Homan	14.2	0	1
Brewin Dolphin	14.2	0	1
Bridgeway Capital Management	14.2	0	1
CIBC Wealth Management	14.2	0	1
CJM Fiscal Management	14.2	0	1
Calvert Investments	14.2	0	1
Charles Stanley & Co. Limited	14.2	0	1
Chauncey Starr	14.2	0	1
Child Trust Fund	14.2	0	1
Clarium Capital	14.2	0	1
Colonial First State	14.2	0	1
Commission on Risk Assessment and Risk Management	14.2	0	1
Confluence	14.2	0	1
Core damage frequency	14.2	0	1
Coverdell Education Savings Account	14.2	0	1
Cyclical tactical asset allocation	14.2	0	1
DREAD (risk assessment model)	14.2	0	1
Donor Managed Investment Account	14.2	0	1
Dreyfus Corporation	14.2	0	1
Dynamic asset allocation	14.2	0	1
Eagle Cash	14.2	0	1
Eaton Vance	14.2	0	1
Ecolego	14.2	0	1
ecological assessment	14.2	0	1
portfolio	14.2	0	1
Elliott Investment Management	14.2	0	1
Evercore Wealth Management	14.2	0	1
expense ratio	14.2	0	1
Fiduciary Trust Company International	14.2	0	1
First Command Financial Planning	14.2	0	1
First Eagle Funds	14.2	0	1
flood risk assessment	14.2	0	1
Form 696	14.2	0	1
Fullerton Securities	14.2	0	1
Fundsmith	14.2	0	1
Gartmore Group	14.2	0	1
Generation Investment Management	14.2	0	1
Global tactical asset allocation	14.2	0	1
Goal-based investing	14.2	0	1
Golden Gate Capital	14.2	0	1
HBK Investments	14.2	0	1
Harbert Management Corporation	14.2	0	1
Harvard Management Company	14.2	0	1
hazard identification	14.2	0	1
Highbridge Capital Management	14.2	0	1
Highland Capital Management	14.2	0	1
Hilliard Lyons	14.2	0	1
Huljich Wealth Management (NZ) Ltd	14.2	0	1
IBM Rational Focal Point	14.2	0	1
IGM Financial	14.2	0	1
IT portfolio management	14.2	0	1
Moore Capital Management	14.2	0	1
individual savings account	14.2	0	1
Individual retirement account	14.2	0	1
intelligence-led policing	14.2	0	1
Investment Management Association	14.2	0	1
Investment outsourcing	14.2	0	1
J. B. Hanauer	14.2	0	1
Khan Investment Management	14.2	0	1
Category:Investment management companies of France	14.2	0	1
LaSalle Investment Management	14.2	0	1
Paul Singer	14.2	0	1
Loomis, Sayles & Company	14.2	0	1
Lord Abbett	14.2	0	1
MFS Investment Management	14.2	0	1
Mackenzie Investments	14.2	0	1
Mattioli Woods	14.2	0	1
Mercury Asset Management	14.2	0	1
Michael Wilson	14.2	0	1
Modified Dietz method	14.2	0	1
molecular risk assessment	14.2	0	1
Neptune Investment Management Novices' Hurdle	14.2	0	1
Network Theory in Risk Assessment	14.2	0	1
fund management fee	14.2	0	1
open assessment	14.2	0	1
Operational objective	14.2	0	1
Organizational project management	14.2	0	1
Pacific Corporate Group	14.2	0	1
Pamela Thomas-Graham	14.2	0	1
Plante Moran	14.2	0	1
portfolio manager	14.2	0	1
Princeton Newport Partners	14.2	0	1
private intelligence agency	14.2	0	1
Professional Wealth Management	14.2	0	1
Profit Investment Management	14.2	0	1
Public Sector Credit Framework	14.2	0	1
Quantitative Microbiological Risk Assessment	14.2	0	1
quantitative risk assessment software	14.2	0	1
recurring deposit	14.2	0	1
retirement planning	14.2	0	1
Risk Information Exchange	14.2	0	1
risk parity	14.2	0	1
RiverSource	14.2	0	1
Robertson Stephens	14.2	0	1
Roth IRA	14.2	0	1
Royal London Asset Management	14.2	0	1
SOX 404 top–down risk assessment	14.2	0	1
SVG Capital	14.2	0	1
Salida Capital	14.2	0	1
Saving for Education, Entrepreneurship, and Downpayment	14.2	0	1
Scottish Mortgage Investment Trust	14.2	0	1
Simple Dietz method	14.2	0	1
Spear's Wealth Management Survey	14.2	0	1
Special memorandum account	14.2	0	1
St. James's Place Wealth Management Group	14.2	0	1
State Street Global Advisors	14.2	0	1
synthetic collateralized debt obligation	14.2	0	1
Tactical asset allocation	14.2	0	1
The Journal of Portfolio Management	14.2	0	1
The Journal of Wealth Management	14.2	0	1
Thomson Investment Management News	14.2	0	1
Trading account assets	14.2	0	1
Trevor Rowe	14.2	0	1
Trusts & Estates	14.2	0	1
Truth About Motorways v Macquarie	14.2	0	1
Tsai Capital	14.2	0	1
Bank of America Private Bank	14.2	0	1
USA Capital	14.2	0	1
Unified managed account	14.2	0	1
Verisk Analytics	14.2	0	1
Wash sale	14.2	0	1
Wilshire Advisors	14.2	0	1
Winton Capital Management	14.2	0	1
Yngve Slyngstad	14.2	0	1
Your Disease Risk	14.2	0	1
Category:Alternative investment management companies	14.2	0	1
Creand	14.2	0	1
Category:Investment management companies	14.2	0	1
Category:Investment management companies by country	14.2	0	1
Category:Investment management companies of Austria	14.2	0	1
Category:Investment management companies of Bahrain	14.2	0	1
Category:Investment management companies of Belgium	14.2	0	1
Category:Investment management companies of Canada	14.2	0	1
Category:Investment management companies of Dominica	14.2	0	1
Category:Investment management companies of Germany	14.2	0	1
Category:Investment management companies of Iceland	14.2	0	1
Category:Investment management companies of India	14.2	0	1
Category:Investment management companies of Italy	14.2	0	1
Category:Investment management companies of Kuwait	14.2	0	1
Category:Investment management companies of Liechtenstein	14.2	0	1
Category:Investment management companies of Norway	14.2	0	1
Category:Investment management companies of South Africa	14.2	0	1
Category:Investment management companies of South Korea	14.2	0	1
Category:Investment management companies of Switzerland	14.2	0	1
Category:Investment management companies of Taiwan	14.2	0	1
Category:Investment management companies of Ukraine	14.2	0	1
Category:Investment management companies of the Netherlands	14.2	0	1
Category:Investment management companies of the United Kingdom	14.2	0	1
Category:Investment management companies of the United States	14.2	0	1
Category:Investment management companies of Japan	14.2	0	1
Banco Carregosa	14.2	0	1
Van Eck Global	14.2	0	1
Industrial Alliance	14.2	0	1
Mizuho Private Wealth Management	14.2	0	1
PAG Investment Management	14.2	0	1
Wealth Management	14.2	0	1
Sumitomo Mitsui Trust Real Estate Investment Management	14.2	0	1
Tokio Marine Property Investment Management	14.2	0	1
Kamakura Investment Management	14.2	0	1
Q11817172	14.2	0	1
Formue	14.2	0	1
Norges Bank Investment Management	14.2	0	1
workplace assessment	14.2	0	1
Trigon Wealth Management	14.2	0	1
Altshuler Shaham	14.2	0	1
Separately managed account	14.2	0	1
Gluskin Sheff	14.2	0	1
Template:Investment management	14.2	0	1
Frederick Warner	14.2	0	1
Break-even	14.2	0	1
Category:Investment management companies of Pakistan	14.2	0	1
Category:Investment management companies of Turkey	14.2	0	1
Investment Management and Financial Innovations	14.2	0	1
International Journal of Risk Assessment and Management	14.2	0	1
Human and Ecological Risk Assessment: An International Journal	14.2	0	1
Villanova Journal of Law and Investment Management	14.2	0	1
Stochastic Environmental Research and Risk Assessment	14.2	0	1
Journal of Soils and Sediments	14.2	0	1
Q15783561	14.2	0	1
Journal of Investment Management	14.2	0	1
Journal of Project, Program and Portfolio Management	14.2	0	1
Kapitalanlagegesetzbuch	14.2	0	1
Werner Baumann	14.2	0	1
portfolio management	14.2	0	1
Investment controlling	14.2	0	1
Zero balance account	14.2	0	1
Carhart four-factor model	14.2	0	1
Strategic Flood Risk Assessment	14.2	0	1
Baring Asset Management	14.2	0	1
Meyer Bergman	14.2	0	1
efficient frontier	14.2	0	1
Addepar	14.2	0	1
Interdepartmental Liaison Group on Risk Assessment	14.2	0	1
Brandywine Asset Management	14.2	0	1
Davidson Kempner Capital Management	14.2	0	1
ISO/IEC 31010	14.2	0	1
Automotive Safety Integrity Level	14.2	0	1
Investment Management Consultants Association	14.2	0	1
Price return	14.2	0	1
Roma Education Fund	14.2	0	1
Payden & Rygel	14.2	0	1
Putnam Investments	14.2	0	1
Indo Premier Investment Management	14.2	0	1
New City Initiative	14.2	0	1
Neptune Investment Management Novices' Hurdle	14.2	0	1
Resampled efficient frontier	14.2	0	1
Worth	14.2	0	1
Risk assessment for organic swine health	14.2	0	1
Lemelson Capital Management	14.2	0	1
Wealth management product	14.2	0	1
Category:Qatar investment management companies	14.2	0	1
Category:Singapore investment management companies	14.2	0	1
Category:Investment management companies of Saudi Arabia	14.2	0	1
FG Hemisphere	14.2	0	1
Atlantic Investment Management	14.2	0	1
hora.gv.at	14.2	0	1
evidence-based policing	14.2	0	1
operational risk management	14.2	0	1
Product Portfolio Management	14.2	0	1
Animal Cloning: A Risk Assessment	14.2	0	1
JUPITER INVESTMENT MANAGEMENT GROUP LIMITED	14.2	0	1
Capula Investment Management	14.2	0	1
Waverton Investment Management	14.2	0	1
UNICEF Goodwill Ambassador	14.2	0	1
Q20459708	14.2	0	1
National Centre for Laboratory Research and Risk Assessment	14.2	0	1
BlueMountain Capital	14.2	0	1
Hermes Investment Management	14.2	0	1
Greg N. Gregoriou	14.2	0	1
Allan Gray Investment Management	14.2	0	1
Resistance to the novel fungicide pyrimorph in Phytophthora capsici: risk assessment and detection of point mutations in CesA3 that confer resistance	14.2	0	1
Robo-advisor	14.2	0	1
Authorship bias in violence risk assessment? A systematic review and meta-analysis	14.2	0	1
The contribution of major depression to the global burden of ischemic heart disease: a comparative risk assessment	14.2	0	1
Cancer risk assessment of ethyl carbamate in alcoholic beverages from Brazil with special consideration to the spirits cachaça and tiquira	14.2	0	1
Pesticide Residues and Bees – A Risk Assessment	14.2	0	1
The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors	14.2	0	1
Rat feeding studies with genetically modified maize - a comparative evaluation of applied methods and risk assessment standards	14.2	0	1
Abu Dhabi Financial Group	14.2	0	1
TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation : An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy	14.2	0	1
Ethical considerations in first-trimester Down syndrome risk assessment	14.2	0	1
Enhancing patient autonomy with risk assessment and invasive diagnosis: an ethical solution to a clinical challenge	14.2	0	1
Ethical considerations of early (first vs. second trimester) risk assessment disclosure for trisomy 21 and patient choice in screening versus diagnostic testing	14.2	0	1
Power Posing: Brief Nonverbal Displays Affect Neuroendocrine Levels and Risk Tolerance	14.2	0	1
Influenza pandemic periodicity, virus recycling, and the art of risk assessment	14.2	0	1
Risk assessment for yellow fever in western and North-Western provinces of Zambia	14.2	0	1
Armstrong Investment Managers	14.2	0	1
Digital repository audit method based on risk assessment	14.2	0	1
Risk Assessment under the Sanitary and Phytosanitary Agreement	14.2	0	1
Hamblin Watsa Investment Counsel Ltd.	14.2	0	1
Jay Jacobs	14.2	0	1
Mayfair Capital Investment Management	14.2	0	1
margin of exposure	14.2	0	1
Newton Investment Management	14.2	0	1
LendingRobot	14.2	0	1
DeSimone Consulting Engineering	14.2	0	1
Epidemiologic approaches to risk assessment	14.2	0	1
An introduction to the use of physiologically based pharmacokinetic models in risk assessment	14.2	0	1
Uncertainty in risk assessment: current efforts and future hopes	14.2	0	1
Physicochemical characteristics of aerosol particles generated during the milling of beryllium silicate ores: implications for risk assessment	14.2	0	1
Assessing biomarker use in risk assessment - a survey of practitioners	14.2	0	1
Lognormal model for determining dose-response curves from epidemiological data and for health risk assessment	14.2	0	1
Health Risk Assessment of Fluctuating Concentrations Using Lognormal Models	14.2	0	1
New perspectives for in vitro risk assessment of multiwalled carbon nanotubes: application of coculture and bioinformatics	14.2	0	1
Incorporating genetics and genomics in risk assessment for inhaled manganese: from data to policy	14.2	0	1
Authors' response to the letter to the editor: “Definition of sleep duration and carotid artery intima media thickness: Caution for risk assessment”	14.2	0	1
32P-postlabelling analysis of DNA adducts of 4,4'-methylenebis(2-chloroaniline) in target and nontarget tissues in the dog and their implications for human risk assessment	14.2	0	1
An approach to risk assessment for TiO2	14.2	0	1
Neurobehavioral testing in human risk assessment	14.2	0	1
Lung dosimetry and risk assessment of nanoparticles: evaluating and extending current models in rats and humans	14.2	0	1
Comparison of human lung dosimetry models: implications for risk assessment	14.2	0	1
Advances in inhalation dosimetry models and methods for occupational risk assessment and exposure limit derivation	14.2	0	1
Risk Assessment and Risk Management of Nanomaterials in the Workplace: Translating Research to Practice	14.2	0	1
Carbon nanotube risk assessment: implications for exposure and medical monitoring	14.2	0	1
Hazard and risk assessment of workplace exposure to engineered nanoparticles: methods, issues, and carbon nanotube case study	14.2	0	1
Significance of genetic information in risk assessment and individual classification using silicosis as a case model	14.2	0	1
A mathematical modeling approach to risk assessment for normal and anemic women chronically exposed to carbon monoxide from biomass-fueled cookstoves	14.2	0	1
Crystalline silica exposure and lung cancer mortality in diatomaceous earth industry workers: a quantitative risk assessment	14.2	0	1
Risk assessment and occupational health. Conceptual problems	14.2	0	1
The evolution of skin notations for occupational risk assessment: A new NIOSH strategy	14.2	0	1
Kurtosis corrected sound pressure level as a noise metric for risk assessment of occupational noises	14.2	0	1
Approaches to risk assessment of immunotoxic effects of chemicals	14.2	0	1
Improving risk assessment: priorities for epidemiologic research	14.2	0	1
Risk Assessment of panelized wall systems in residential construction using critical incident technique	14.2	0	1
Safety evaluation and risk assessment using immunotoxicology methods	14.2	0	1
Immunotoxicology - regulatory and risk assessment concepts	14.2	0	1
Occupational injury risk assessment: an unintended and unanticipated consequence of the red book	14.2	0	1
Occupational injury risk assessment: perspective and introduction to the second special issue	14.2	0	1
Surfactant effects on skin absorption of model organic chemicals: implications for dermal risk assessment studies	14.2	0	1
Risk assessment - the mother of all uncertainties. Disciplinary perspectives on uncertainty in risk assessment	14.2	0	1
Common themes at the workshop on uncertainty in the risk assessment of environmental and occupational hazards	14.2	0	1
Interindividual variance of cytochrome P450 forms in human hepatic microsomes: correlation of individual forms with xenobiotic metabolism and implications in risk assessment	14.2	0	1
Machinery risk assessment for risk reduction	14.2	0	1
Reducing risk on machinery: a field evaluation pilot study of risk assessment	14.2	0	1
Pooled exposure-response analyses and risk assessment for lung cancer in 10 cohorts of silica-exposed workers: an IARC multicentre study	14.2	0	1
Risk assessment for 2,3,7,8-p-dioxin (TCDD) based on an epidemiologic study	14.2	0	1
A practical guide to dose-response analyses and risk assessment in occupational epidemiology	14.2	0	1
Dioxin: exposure-response analyses and risk assessment	14.2	0	1
Carbon nanotubes exposure risk assessment: From toxicology to epidemiologic studies (Overview of the current problem)	14.2	0	1
Improving risk assessment: research opportunities in dose response modeling to improve risk assessment	14.2	0	1
Risk assessment at the crossroads of the 21st century: opportunities and challenges for research	14.2	0	1
Sources of uncertainty in dose-response modeling of epidemiological data for cancer risk assessment	14.2	0	1
Occupational injury risk assessment: perspective and introduction	14.2	0	1
Occupational injury risk assessment: perspective and introduction to the first special issue	14.2	0	1
Improving risk assessment: toxicological research needs	14.2	0	1
Global challenges in the risk assessment of nanomaterials: relevance to South Africa	14.2	0	1
Developments in asbestos cancer risk assessment	14.2	0	1
Health risk assessment for nanoparticles: a case for using expert judgment	14.2	0	1
Health risk assessment of occupational exposure to hazardous volatile organic compounds in swine gestation, farrowing and nursery barns	14.2	0	1
Considerations for Using Genetic and Epigenetic Information in Occupational Health Risk Assessment and Standard Setting	14.2	0	1
Using molecular epidemiology in assessing exposure for risk assessment	14.2	0	1
Cumulative Risk Assessment (CRA): Transforming the Way We Assess Health Risks	14.2	0	1
Molecular biomarkers and epidemiologic risk assessment	14.2	0	1
Children's health and the environment: public health issues and challenges for risk assessment	14.2	0	1
CYP1A induction and human risk assessment: an evolving tale of in vitro and in vivo studies	14.2	0	1
Exposure to crystalline silica, silicosis, and lung disease other than cancer in diatomaceous earth industry workers: a quantitative risk assessment	14.2	0	1
Benzene exposure and hematopoietic mortality: a long-term epidemiologic risk assessment	14.2	0	1
Benzene and leukemia. An epidemiologic risk assessment	14.2	0	1
Issues in neurological risk assessment for occupational exposures: the Bay Bridge welders	14.2	0	1
Exposure-response relationship and risk assessment for cognitive deficits in early welding-induced manganism	14.2	0	1
Hexavalent chromium and lung cancer in the chromate industry: a quantitative risk assessment	14.2	0	1
Immunotoxicogenomics: the potential of genomics technology in the immunotoxicity risk assessment process	14.2	0	1
A quantitative look at fluorosis, fluoride exposure, and intake in children using a health risk assessment approach	14.2	0	1
Aggregate Exposure and Cumulative Risk Assessment—Integrating Occupational and Non-occupational Risk Factors	14.2	0	1
Validation of biological markers for quantitative risk assessment	14.2	0	1
Biologic markers in risk assessment for environmental carcinogens	14.2	0	1
Benzene and leukemia: an epidemiologic risk assessment	14.2	0	1
Meeting report: moving upstream-evaluating adverse upstream end points for improved risk assessment and decision-making	14.2	0	1
Autoimmunity and risk assessment	14.2	0	1
Risk assessment for heart disease and workplace ETS exposure among nonsmokers	14.2	0	1
Environment and health: 9. The science of risk assessment	14.2	0	1
Exposure to silica and silicosis among tin miners in China: exposure response analyses and risk assessment	14.2	0	1
Dissolution and biodurability: Important parameters needed for risk assessment of nanomaterials	14.2	0	1
Exposure-response analysis and risk assessment for lung cancer in relationship to silica exposure: a 44-year cohort study of 34,018 workers	14.2	0	1
Hunter Hall Investment Management Ltd	14.2	0	1
FIL Investment Services (UK) Limited	14.2	0	1
FIL Investments International	14.2	0	1
Majedie Asset Management	14.2	0	1
Worldview Capital Management	14.2	0	1
Diesel exhaust and lung cancer in the trucking industry: Exposure-response analyses and risk assessment	14.2	0	1
Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cells	14.2	0	1
NIOSH Testimony on a Cross-Species Scaling Factor for Carcinogen Risk Assessment Based on Equivalence of mg/kg3/4/Day by R. W. Niemeier, August 4, 1992	14.2	0	1
Quantitative risk assessment of lung cancer in U.S. uranium miners	14.2	0	1
Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular disease	14.2	0	1
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease	14.2	0	1
Risk assessment tools for the prevention of pressure ulcers	14.2	0	1
Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular disease	14.2	0	1
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease	14.2	0	1
Biomedical risk assessment as an aid for smoking cessation	14.2	0	1
Cancer genetic risk assessment for individuals at risk of familial breast cancer	14.2	0	1
Biomedical risk assessment as an aid for smoking cessation	14.2	0	1
Risk assessment tools for the prevention of pressure ulcers	14.2	0	1
Cancer genetic risk assessment for individuals at risk of familial breast cancer	14.2	0	1
Biomedical risk assessment as an aid for smoking cessation	14.2	0	1
Risk assessment tools for the prevention of pressure ulcers	14.2	0	1
Biomedical risk assessment as an aid for smoking cessation	14.2	0	1
Q24254409	14.2	0	1
A glutaraldehyde risk assessment using benchmark doses: decisions, decisions, decisions!	14.2	0	1
Risk assessment's New Era: Part 1: Challenges for Industrial Hygiene	14.2	0	1
Development of a biomarker decision support system for use in occupational risk assessment	14.2	0	1
Basic exploratory research versus guideline-compliant studies used for hazard evaluation and risk assessment: bisphenol A as a case study	14.2	0	1
Risk assessment and communication tools for genotype associations with multifactorial phenotypes: the concept of "edge effect" and cultivating an ethical bridge between omics innovations and society	14.2	0	1
Toxicogenomic profiling of chemically exposed humans in risk assessment	14.2	0	1
A quantitative risk assessment of 1-bromopropane, based on tumor data	14.2	0	1
Human campylobacteriosis related to the consumption of raw milk sold by vending machines in Italy: Quantitative risk assessment based on official controls over four years	14.2	0	1
Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air	14.2	0	1
Hormesis: a revolution in toxicology, risk assessment and medicine	14.2	0	1
An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment	14.2	0	1
Risk assessment and control of waterborne giardiasis	14.2	0	1
Risk assessment after acute upper gastrointestinal haemorrhage	14.2	0	1
Mechanisms of multistep carcinogenesis and carcinogen risk assessment	14.2	0	1
Impact of Bt corn pollen on monarch butterfly populations: a risk assessment	14.2	0	1
Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review	14.2	0	1
Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment	14.2	0	1
musculoskeletal risk assessment tool	14.2	0	1
The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy	14.2	0	1
Recommendations for the design of laboratory studies on non-target arthropods for risk assessment of genetically engineered plants	14.2	0	1
Use of multi-objective air pollution monitoring sites and online air pollution monitoring system for total health risk assessment in Hyderabad, India	14.2	0	1
Risk of "silent stroke" in patients older than 60 years: risk assessment and clinical perspectives	14.2	0	1
Pesticide Exposure, Safety Issues, and Risk Assessment Indicators	14.2	0	1
Human health risk assessment of pharmaceuticals in water: issues and challenges ahead	14.2	0	1
Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia	14.2	0	1
Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis	14.2	0	1
Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease	14.2	0	1
Population-based fracture risk assessment and osteoporosis treatment disparities by race and gender	14.2	0	1
Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists	14.2	0	1
Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke	14.2	0	1
Second hand smoke and risk assessment: what was in it for the tobacco industry?	14.2	0	1
A public health context for residual risk assessment and risk management under the clean air act	14.2	0	1
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT	14.2	0	1
Using epidemiologic data for a risk assessment of silica exposure	14.2	0	1
Risk Assessment's New Era, Part 4: Roadmap for Integrating Risk and Decision Making into Industrial Hygiene	14.2	0	1
Associating changes in the immune system with clinical diseases for interpretation in risk assessment	14.2	0	1
Workshop series: control banding: a risk assessment tool for joint labor/management health and safety committees	14.2	0	1
Job level risk assessment using task level strain index scores: a pilot study	14.2	0	1
Risk assessment and regulation of carcinogens in the workplace	14.2	0	1
Major hazard risk assessment applied to pillar recovery operations	14.2	0	1
Using major hazard risk assessment to appraise and manage escapeway instability issues: a case study	14.2	0	1
Use of genomic data in risk assessment	14.2	0	1
Air pollution attributable postneonatal infant mortality in U.S. metropolitan areas: a risk assessment study	14.2	0	1
Prediction of falls using a risk assessment tool in the acute care setting	14.2	0	1
VTE Risk assessment - a prognostic Model: BATER Cohort Study of young women	14.2	0	1
The utility of ductal lavage in breast cancer detection and risk assessment	14.2	0	1
Viability testing of material derived from Mycobacterium tuberculosis prior to removal from a containment level-III laboratory as part of a Laboratory Risk Assessment Program	14.2	0	1
Conflict and HIV: A framework for risk assessment to prevent HIV in conflict-affected settings in Africa	14.2	0	1
Evaluation and use of epidemiological evidence for environmental health risk assessment: WHO guideline document	14.2	0	1
Ecological risk assessment of endocrine disruptors	14.2	0	1
Predicting the risk of falling--efficacy of a risk assessment tool compared to nurses' judgement: a cluster-randomised controlled trial [ISRCTN37794278].	14.2	0	1
Human Exposure: the key to better risk assessment	14.2	0	1
Toxicogenomics in risk assessment: an overview of an HESI collaborative research program	14.2	0	1
The importance of population susceptibility for air pollution risk assessment: a case study of power plants near Washington, DC	14.2	0	1
Personal exposure meets risk assessment: a comparison of measured and modeled exposures and risks in an urban community	14.2	0	1
Evaluating cumulative risk assessment for environmental justice: a community case study	14.2	0	1
Problems for risk assessment of endocrine-active estrogenic compounds	14.2	0	1
Risk assessment at the EPA: an agency self-exam	14.2	0	1
Some considerations concerning multimedia-multipollutant risk assessment methodology: use of epidemiologic data for non-cancer risk assessment in Russia	14.2	0	1
Toxicogenomics in risk assessment: communicating the challenges	14.2	0	1
Re: Risk Assessment of Internal Cancers from Arsenic in Drinking Water	14.2	0	1
Methods to identify and characterize developmental neurotoxicity for human health risk assessment: overview	14.2	0	1
Methods to identify and characterize developmental neurotoxicity for human health risk assessment. I: behavioral effects	14.2	0	1
Methods to identify and characterize developmental neurotoxicity for human health risk assessment. II: neuropathology	14.2	0	1
Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: pharmacokinetic and pharmacodynamic considerations	14.2	0	1
Ethics assessment as an adjunct to risk assessment in the evaluation of developmental neurotoxicants	14.2	0	1
Health and environment information systems for exposure and disease mapping, and risk assessment	14.2	0	1
A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment	14.2	0	1
Cancer risk assessment for arsenic exposure through oyster consumption.	14.2	0	1
An assessment of the cord blood:maternal blood methylmercury ratio: implications for risk assessment	14.2	0	1
Risk assessment. Genes express dissatisfaction with environment	14.2	0	1
Cumulative organophosphate pesticide exposure and risk assessment among pregnant women living in an agricultural community: a case study from the CHAMACOS cohort	14.2	0	1
Toxicogenomic applications to drug risk assessment	14.2	0	1
A training strategy that involves all employees in workplace risk assessment	14.2	0	1
Capturing and modeling human interindividual differences for health risk assessment: hepatic bioactivation of chloroform	14.2	0	1
Risk assessment approaches and research needs for nanomaterials: an examination of data and information from current studies	14.2	0	1
Rebellion Research	14.2	0	1
Risk-need-responsivity model	14.2	0	1
Local lymph node assay as a quantitative risk assessment tool to model biologic skin response of allergic contact dermatitis in the mouse	14.2	0	1
Orbis Investment Management	14.2	0	1
A quantitative risk assessment of 2, 3-pentanedione, based on preliminary data	14.2	0	1
Comparison of ergonomic risk assessment outputs from Rapid Upper Limb Assessment and the Strain Index for tasks in automotive assembly plants	14.2	0	1
Lung dosimetry models in rats and humans: use and evaluation for risk assessment of nanoparticles	14.2	0	1
A quantitative risk assessment in workers using rodent dose-response data of fine and ultrafine titanium dioxide	14.2	0	1
Molecular basis of genetic risk assessment in chronic beryllium disease	14.2	0	1
Exposure-response analysis and risk assessment for silica and silicosis mortality in a pooled analysis of six cohorts	14.2	0	1
New York Life Investments	14.2	0	1
Single-walled carbon nanotubes induce fibrogenic response by promoting epithelial/fibroblast-to-myofibroblast transition: an in vitro molecular toxicity pathway based risk assessment	14.2	0	1
A human-health risk assessment for West Nile virus and insecticides used in mosquito management	14.2	0	1
Bisphenol A and risk assessment	14.2	0	1
Inter-organisational integration for rehabilitation in Sweden - variation in views on long-term goals.	14.2	0	1
Category:Investment management companies of Malaysia	14.2	0	1
Category:Investment management companies of Haiti	14.2	0	1
Portfolio Management Professional	14.2	0	1
Q25454752	14.2	0	1
Focus on prevention: conducting a hazard risk assessment	14.2	0	1
Risk assessment's new era - part 2: evolving methods and future directions	14.2	0	1
The application of major hazard risk assessment (MHRA) to eliminate multiple fatality occurrences in the U.S. minerals industry	14.2	0	1
Development of risk assessment method for complex noise	14.2	0	1
Don Brownstein	14.2	0	1
Risk assessment committee: seeking solutions for hazards old and new	14.2	0	1
Of mice men and models: future research for improving risk assessment methods	14.2	0	1
Introduction to risk assessment	14.2	0	1
Lung dosimetry and risk assessment for nanoparticles: use of in vitro and in vivo data to extend current models in rats and humans	14.2	0	1
Addressing uncertainty in epidemiologically based risk assessment	14.2	0	1
Applying the modern principles of risk assessment to protect workers: update of the derivation methods for Immediately Dangerous to Life and Health (IDLH) values	14.2	0	1
Job level risk assessment using task level ACGIH hand activity level TLV scores: a pilot study	14.2	0	1
Quantitative risk assessment as the basis for a proposed NIOSH recommended exposure limit for hexavalent chromium compounds	14.2	0	1
Risk Assessment's New Era, Part 3: Vision of the AIHA(®) Risk Assessment Committee	14.2	0	1
Uncertainty in the risk assessment of environmental and occupational hazards	14.2	0	1
Epidemiology and risk assessment	14.2	0	1
Structured Portfolio Management	14.2	0	1
Hexavalent chromium and lung cancer in the chromate industry: a quantitative risk assessment	14.2	0	1
Hexavalent chromium and lung cancer in the chromate industry: a quantitative risk assessment	14.2	0	1
Värde Partners	14.2	0	1
Silica exposure and silicosis among tin miners in China: exposure response analyses and risk assessment	14.2	0	1
Human health risk assessment	14.2	0	1
Quantitative risk assessment of lung cancer in U.S. uranium miners	14.2	0	1
Focus on prevention: conducting a fire risk assessment	14.2	0	1
Risk assessment activities at NIOSH: information resources and need	14.2	0	1
Methodologic issues in using epidemiologic studies for quantitative risk assessment	14.2	0	1
Exposure assessment in risk assessment	14.2	0	1
Methodologic and ethical issues in epidemiologic risk assessment of occupational hazards	14.2	0	1
Interactions between occupational and environmental factors in toxicology, hazard evaluation and risk assessment	14.2	0	1
Risk assessment and public policy	14.2	0	1
Emerging needs in epidemiology and risk assessment	14.2	0	1
Notes on the contribution of epidemiology to health risk assessment	14.2	0	1
Risk assessment of pulmonary exposure to respirable dust while wearing dust respirator under simulated work conditions	14.2	0	1
The morals of risk assessment	14.2	0	1
A time-to-tumor approach to 1,3-butadiene risk assessment	14.2	0	1
Risk assessment of a cohort exposed to aromatic amines. Initial results	14.2	0	1
Notification and risk assessment for bladder cancer of a cohort exposed to aromatic amines. III. Mortality among workers exposed to aromatic amines in the last [beta]-naphthylamine manufacturing facility in the United States	14.2	0	1
Paraquat and marijuana: epidemiologic risk assessment	14.2	0	1
Silicosis among gold miners: exposure - response analyses and risk assessment	14.2	0	1
Quantitative biochemical markers of DNA hyperploidy as end-point indicators in chemical risk assessment and chemoprevention studies	14.2	0	1
Time-to-Tumour Risk Assessment for 1,3-Butadiene Based on Exposure of Mice to Low Doses by Inhalation	14.2	0	1
Risk Assessment and Occupational Health: Overview and Recommendations	14.2	0	1
Methodologic issues in using epidemiologic studies of occupational cohorts for cancer risk assessment	14.2	0	1
Special issue: occupational risk assessment	14.2	0	1
Immunotoxicity: hazard identification and risk assessment	14.2	0	1
Alternatives for hearing loss risk assessment	14.2	0	1
The next generation of risk assessment multi-year study - highlights of findings, applications to risk assessment, and future directions	14.2	0	1
NIOSH Testimony on Neurotoxicity Risk Assessment by R. W. Niemeier, November 2, 1993	14.2	0	1
NIOSH Testimony on Neurotoxicity/Health Risk Assessment by L. Rosenstock, January 30, 1996	14.2	0	1
Risk Assessment and Compliance Cost in the Regulation of	14.2	0	1
Carcinogenic risk assessment for occupational exposure to monohalomethanes. Final report	14.2	0	1
Of mice men and models: future research for improving risk assessment methods, August 16-18, 2000, Aspen, Colorado	14.2	0	1
Epidemiology and health risk assessment. Proceedings of a symposium held May 14 - 16, 1985, Columbia, Maryland	14.2	0	1
Re: "benzene and leukemia: a review of the literature and a risk assessment."	14.2	0	1
Risk Assessment and Control of Toxic Gas Releases	14.2	0	1
NIOSH testimony on benzene and leukemia: an epidemiologic risk assessment by J. D. Millar, August 9, 1985	14.2	0	1
NIOSH Testimony on Priority Setting and Quantitative Risk Assessment by R. A. Lemen, October 13, 1981	14.2	0	1
K2	14.2	0	1
Nanocomposites in food packaging applications and their risk assessment for health	14.2	0	1
Cardiovascular risk assessment in rheumatoid arthritis - controversies and the new approach	14.2	0	1
Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers	14.2	0	1
Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay	14.2	0	1
Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion	14.2	0	1
Mechanisms and risk assessment of steroid resistance in acute kidney transplant rejection	14.2	0	1
Benefit-Risk Assessment of Fish Oil in Preventing Cardiovascular Disease	14.2	0	1
Fertility Risk Assessment and Preservation in Male and Female Prepubertal and Adolescent Cancer Patients	14.2	0	1
Role of Biomarkers in the Diagnosis, Risk Assessment, and Management of Pulmonary Hypertension	14.2	0	1
Risk assessment in the prevention of cardiovascular disease in low-resource settings	14.2	0	1
Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management	14.2	0	1
A review of crustacean sensitivity to high amplitude underwater noise: Data needs for effective risk assessment in relation to UK commercial species	14.2	0	1
An Insight Into the Immunologic Events and Risk Assessment in Renal Transplantation	14.2	0	1
Multiparametric MRI and targeted prostate biopsy: Improvements in cancer detection, localization, and risk assessment	14.2	0	1
Evaluation of relative effect potencies (REPs) for dioxin-like compounds to derive systemic or human-specific TEFs to improve human risk assessment	14.2	0	1
Benefit-risk assessment of golimumab in the treatment of refractory ulcerative colitis	14.2	0	1
Immunological risk assessment: The key to individualized immunosuppression after kidney transplantation	14.2	0	1
Diabetes Mellitus, Arterial Wall, and Cardiovascular Risk Assessment	14.2	0	1
Under the Cartagena Protocol on Biosafety – Where is the Roadmap for Risk Assessment Taking Us?	14.2	0	1
Risk assessment of drug-induced QT prolongation	14.2	0	1
Biosafety research for non-target organism risk assessment of RNAi-based GE plants	14.2	0	1
Suicide risk assessment and intervention in people with mental illness	14.2	0	1
Consideration on the health risk reduction related to attainment of the new particulate matter standards in Poland: A top-down policy risk assessment approach	14.2	0	1
Relevance of Crop Biology for Environmental Risk Assessment of Genetically Modified Crops in Africa	14.2	0	1
Caries management by risk assessment: A review on current strategies for caries prevention and management	14.2	0	1
Low-level arsenic exposure and developmental neurotoxicity in children: A systematic review and risk assessment	14.2	0	1
Applicability of the Existing CVD Risk Assessment Tools to Type II Diabetics in Oman: A Review	14.2	0	1
Cancer risk assessment tools in primary care: a systematic review of randomized controlled trials	14.2	0	1
Molecular bio-dosimetry for carcinogenic risk assessment in survivors of Bhopal gas tragedy	14.2	0	1
Nutritional risk assessment in critically ill cancer patients: systematic review	14.2	0	1
Proposed criteria for identifying GE crop plants that pose a low or negligible risk to the environment under conditions of low-level presence in seed	14.2	0	1
Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran	14.2	0	1
Regulatory risk assessment approaches for synthetic mineral fibres	14.2	0	1
Review of fall risk assessment in geriatric populations using inertial sensors	14.2	0	1
Evaluation of Epidemiology and Animal Data for Risk Assessment: Chlorpyrifos Developmental Neurobehavioral Outcomes	14.2	0	1
Q26824494	14.2	0	1
Risk Assessment and Guidelines for the Management of High Triglycerides	14.2	0	1
The pollution character analysis and risk assessment for metals in dust and PM10 around road from China	14.2	0	1
The myth of the "vulnerable plaque": transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment	14.2	0	1
Improving the risk assessment of lipophilic persistent environmental chemicals in breast milk	14.2	0	1
Community Health Risk Assessment of Primary Aluminum Smelter Emissions	14.2	0	1
Q26861376	14.2	0	1
Evaluation of the performance of existing non-laboratory based cardiovascular risk assessment algorithms	14.2	0	1
Q26866267	14.2	0	1
Patient representatives' contributions to the benefit-risk assessment tasks of the European Medicines Agency scientific committees	14.2	0	1
Uncertainty in the Risk Assessment of Environmental and Occupational Hazards : an International Workshop	14.2	0	1
Northern Cross	14.2	0	1
Kirkbi Invest	14.2	0	1
Alternative BSE Risk Assessment Methodology for Beef and Beef Offal Imported into Japan	14.2	0	1
Review on the Risk Assessment of Heavy Metals in Malaysian Clams	14.2	0	1
Genetically engineered trees for plantation forests: key considerations for environmental risk assessment	14.2	0	1
Use of risk assessment instruments to predict violence and antisocial behaviour in 73 samples involving 24 827 people: systematic review and meta-analysis	14.2	0	1
Risk Assessment and Guidelines for the Management of High Blood Cholesterol	14.2	0	1
Preoperative risk assessment--from routine tests to individualized investigation	14.2	0	1
Advancing human health risk assessment: integrating recent advisory committee recommendations	14.2	0	1
Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate	14.2	0	1
Risk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkers	14.2	0	1
Anaphylaxis: opportunities of stratified medicine for diagnosis and risk assessment	14.2	0	1
A systematic review of risk assessment strategies for populations at high risk of engaging in violent behaviour: update 2002-8	14.2	0	1
Risk Assessment in the Federal Government	14.2	0	1
Comparative Risk Assessment of Formulation Changes in Generic Drug Products: A Pharmacology/Toxicology Perspective	14.2	0	1
Human H7N9 avian influenza virus infection: a review and pandemic risk assessment	14.2	0	1
Q27025983	14.2	0	1
Risk Assessment in Neonatal Early Onset Sepsis	14.2	0	1
Systematic review and meta-analysis of the performance of clinical risk assessment instruments for screening for osteoporosis or low bone density	14.2	0	1
Rational environmental management of agrochemicals : risk assessment, monitoring, and remedial action	14.2	0	1
Toxicity Testing: New Approaches and Applications in Human Risk Assessment	14.2	0	1
eNanoMapper: harnessing ontologies to enable data integration for nanomaterial risk assessment	14.2	0	1
Risk assessment of sheep welfare at small-scale slaughter in Nordic countries, comparing with large-scale slaughter	14.2	0	1
Integrated cryptosporidium assay to determine oocyst density, infectivity, and genotype for risk assessment of source and reuse water	14.2	0	1
Bluetongue Disease Risk Assessment Based on Observed and Projected Culicoides obsoletus spp. Vector Densities	14.2	0	1
Multicenter study on caries risk assessment in adults using survival Classification and Regression Trees	14.2	0	1
Predicting outbreaks: a spatial risk assessment of West Nile virus in British Columbia	14.2	0	1
A facet of the biohazard control program: agent registration, risk assessment and computerization of data	14.2	0	1
Structural and mechanistic insights into bisphenols action provide guidelines for risk assessment and discovery of bisphenol A substitutes	14.2	0	1
Evidence-based risk assessment and recommendations for physical activity clearance: pregnancy	14.2	0	1
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.	14.2	0	1
Dorsal Capital Management, LLC	14.2	0	1
An ensemble model of QSAR tools for regulatory risk assessment	14.2	0	1
An exploratory risk assessment for metalworking fluids (MWFS)	14.2	0	1
Risk assessment: conventional diesel exhaust and lung cancer	14.2	0	1
Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment	14.2	0	1
Non-chemical risk assessment for lifting and low back pain based on Bayesian threshold models	14.2	0	1
Cardiovascular risk assessment in patients with a severe mental illness: a systematic review and meta-analysis	14.2	0	1
Risk assessment in pulmonary arterial hypertension	14.2	0	1
Beyond breast density: a review on the advancing role of parenchymal texture analysis in breast cancer risk assessment	14.2	0	1
Development of a construct-based risk assessment framework for genetic engineered crops	14.2	0	1
Key Challenges and Opportunities Associated with the Use of In Vitro Models to Detect Human DILI: Integrated Risk Assessment and Mitigation Plans	14.2	0	1
Systematic review on tuberculosis transmission on aircraft and update of the European Centre for Disease Prevention and Control risk assessment guidelines for tuberculosis transmitted on aircraft (RAGIDA-TB)	14.2	0	1
The use of peptide reactivity assays for skin sensitisation hazard identification and risk assessment	14.2	0	1
Biomechanical Rupture Risk Assessment: A Consistent and Objective Decision-Making Tool for Abdominal Aortic Aneurysm Patients	14.2	0	1
Development, Functioning, and Effectiveness of a Preoperative Risk Assessment Clinic	14.2	0	1
Cancer Genetics Risk Assessment and Counseling (PDQ®): Health Professional Version	14.2	0	1
Using systematic reviews for hazard and risk assessment of endocrine disrupting chemicals	14.2	0	1
Hospital-associated venous thromboembolism in pediatrics: a systematic review and meta-analysis of risk factors and risk assessment models	14.2	0	1
Drinking water studies: a review on heavy metal, application of biomarker and health risk assessment (a special focus in Malaysia)	14.2	0	1
Fractal lacunarity of trabecular bone and magnetic resonance imaging: New perspectives for osteoporotic fracture risk assessment	14.2	0	1
Uses of NHANES Biomarker Data for Chemical Risk Assessment: Trends, Challenges, and Opportunities	14.2	0	1
Environmental (Saprozoic) Pathogens of Engineered Water Systems: Understanding Their Ecology for Risk Assessment and Management	14.2	0	1
A multidisciplinary approach to therapeutic risk management of the suicidal patient	14.2	0	1
Violence risk assessment in psychiatric patients in China: A systematic review	14.2	0	1
Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment?	14.2	0	1
Q28085663	14.2	0	1
Venous thromboembolism in hospitalized adolescents: an approach to risk assessment and prophylaxis	14.2	0	1
Ultrasound imaging for risk assessment in atherosclerosis	14.2	0	1
Transport of toxic dinoflagellates via ships' ballast water:bioeconomic risk assessment and efficacy of possible ballast water management strategies	14.2	0	1
RETRACTED: Safety Evaluation and Risk Assessment of the Herbicide Roundup and Its Active Ingredient, Glyphosate, for Humans	14.2	0	1
Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment tool	14.2	0	1
Benefit-risk assessment of rofecoxib in the treatment of osteoarthritis	14.2	0	1
Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications	14.2	0	1
Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment	14.2	0	1
High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease	14.2	0	1
Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests	14.2	0	1
High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease	14.2	0	1
Cardiovascular risk assessment in patients with retinal vein occlusion	14.2	0	1
A benefit-risk assessment of agents used in the secondary prevention of stroke	14.2	0	1
Coronary and cardiovascular risk estimation in uncomplicated mild hypertension. A comparison of risk assessment methods	14.2	0	1
Risk assessment of hemorrhagic complications associated with nonsteroidal antiinflammatory medications in ambulatory pain clinic patients undergoing epidural steroid injection	14.2	0	1
Is treatment of atrial fibrillation in primary care based on thromboembolic risk assessment?	14.2	0	1
Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study	14.2	0	1
New frontiers for cardiac risk assessment: C-reactive protein	14.2	0	1
High sensitivity C-reactive protein in cardiovascular risk assessment. CRP mania or useful screening?	14.2	0	1
Benefit-risk assessment of treatments for heparin-induced thrombocytopenia	14.2	0	1
Species differences in the metabolism of olefins: implications for risk assessment	14.2	0	1
The release of genetically modified crops into the environment. Part II. Overview of ecological risk assessment	14.2	0	1
PGIM	14.2	0	1
Risk assessment of endogenous formation of carcinogenic N-nitroso compounds in response to intake of NO-aspirin	14.2	0	1
Ecological predictions and risk assessment for alien fishes in North America	14.2	0	1
Risk assessment, drug approval, and liability	14.2	0	1
Multivariate risk assessment and risk score cards in hypertension	14.2	0	1
Risk assessment for children exposed to decabromodiphenyl (oxide) ether (Deca) in the United States	14.2	0	1
Amalgam risk assessment with coverage of references up to 2005	14.2	0	1
Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions	14.2	0	1
Safety of spinal manipulation in the treatment of lumbar disk herniations: a systematic review and risk assessment	14.2	0	1
The ABC's of Suicide Risk Assessment: Applying a Tripartite Approach to Individual Evaluations	14.2	0	1
Hormesis: from marginalization to mainstream: a case for hormesis as the default dose-response model in risk assessment	14.2	0	1
Suicide risk assessment: is clinical experience enough?	14.2	0	1
Value of the sagittal abdominal diameter in coronary heart disease risk assessment: cohort study in a large, multiethnic population	14.2	0	1
Risk assessment for vitamin D	14.2	0	1
Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors	14.2	0	1
Fundamental carcinogenic processes and their implications for low dose risk assessment	14.2	0	1
Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment	14.2	0	1
Risk assessment of the mycotoxin zearalenone	14.2	0	1
Aquatic risk assessment of pesticides in surface waters in and adjacent to the Everglades and Biscayne National Parks: II. Probabilistic analyses	14.2	0	1
Aquatic risk assessment of pesticides in surface waters in and adjacent to the Everglades and Biscayne National Parks: I. Hazard assessment and problem formulation	14.2	0	1
The efficacy of violence prediction: a meta-analytic comparison of nine risk assessment tools	14.2	0	1
Benzene and leukemia. A review of the literature and a risk assessment	14.2	0	1
Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases	14.2	0	1
Risk assessment for drug-drug interaction caused by metabolism-based inhibition of CYP3A using automated in vitro assay systems and its application in the early drug discovery process	14.2	0	1
N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation	14.2	0	1
Melanoma Susceptibility Genes and Risk Assessment	14.2	0	1
A comparative study of violence risk assessment tools: a systematic review and metaregression analysis of 68 studies involving 25,980 participants	14.2	0	1
Risk assessment of genetically modified crops for nutrition and health	14.2	0	1
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids	14.2	0	1
Role of individual susceptibility in risk assessment of pesticides	14.2	0	1
Validation of EGCRISC for Chronic Hepatitis C Infection Screening and Risk Assessment in the Egyptian Population	14.2	0	1
Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach	14.2	0	1
The toxicity of benzene and its metabolism and molecular pathology in human risk assessment	14.2	0	1
Safety evaluation of engineered nanomaterials for health risk assessment: an experimental tiered testing approach using pristine and functionalized carbon nanotubes	14.2	0	1
Fluoride exposure and its health risk assessment in drinking water and staple food in the population of Dayyer, Iran, in 2013	14.2	0	1
Similar anxiolytic effects of agonists targeting serotonin 5-HT1A or cannabinoid CB receptors on zebrafish behavior in novel environments	14.2	0	1
Incorporating Low-dose Epidemiology Data in a Chlorpyrifos Risk Assessment	14.2	0	1
Adverse effects in risk assessment: modeling polychlorinated biphenyls and thyroid hormone disruption outcomes in animals and humans	14.2	0	1
Update on a Pharmacokinetic-Centric Alternative Tier II Program for MMT-Part II: Physiologically Based Pharmacokinetic Modeling and Manganese Risk Assessment	14.2	0	1
Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water	14.2	0	1
Quantitative Microbial Risk Assessment in Occupational Settings Applied to the Airborne Human Adenovirus Infection	14.2	0	1
Pharmaceuticals in Tap Water: Human Health Risk Assessment and Proposed Monitoring Framework in China	14.2	0	1
Non-renal effects and the risk assessment of environmental cadmium exposure	14.2	0	1
Risk Assessment of the Carbon Nanotube Group	14.2	0	1
Guidelines to evaluate human observational studies for quantitative risk assessment	14.2	0	1
Integrating environmental health into nurse practitioner training-childhood pesticide exposure risk assessment, prevention, and management	14.2	0	1
Bisphenol A environmental exposure and the detrimental effects on human metabolic health: is it necessary to revise the risk assessment in vulnerable population?	14.2	0	1
Ten-year Diabetes Risk Forecast in the Capital of Jordan: Arab Diabetes Risk Assessment Questionnaire Perspective-A Strobe-Complaint Article	14.2	0	1
Range-finding risk assessment of inhalation exposure to nanodiamonds in a laboratory environment	14.2	0	1
Potential Effects of Chlorpyrifos on Fetal Growth Outcomes: Implications for Risk Assessment	14.2	0	1
Risk assessment of diesel exhaust and lung cancer: combining human and animal studies after adjustment for biases in epidemiological studies	14.2	0	1
Risk Assessment of Exposure to Silica Dust in Building Demolition Sites	14.2	0	1
Associating Changes in the Immune System with Clinical Diseases for Interpretation in Risk Assessment	14.2	0	1
Performance of two quantitative PCR methods for microbial source tracking of human sewage and implications for microbial risk assessment in recreational waters	14.2	0	1
Health risk assessment of ambient air concentrations of benzene, toluene and xylene (BTX) in service station environments	14.2	0	1
Nano-risk Science: application of toxicogenomics in an adverse outcome pathway framework for risk assessment of multi-walled carbon nanotubes	14.2	0	1
Trends in quantitative cancer risk assessment	14.2	0	1
Use of biological markers and pharmacokinetics in human health risk assessment	14.2	0	1
Benzene toxicity and risk assessment, 1972-1992: implications for future regulation	14.2	0	1
The U.S. Food and Drug Administration risk assessment on lead in women's and children's vitamins is based on outdated assumptions	14.2	0	1
Emerging methods and tools for environmental risk assessment, decision-making, and policy for nanomaterials: summary of NATO Advanced Research Workshop	14.2	0	1
Incorporating epigenetic data into the risk assessment process for the toxic metals arsenic, cadmium, chromium, lead, and mercury: strategies and challenges	14.2	0	1
RadRAT: a radiation risk assessment tool for lifetime cancer risk projection	14.2	0	1
Cancer risk assessment of 1,3-butadiene	14.2	0	1
Perspectives on the risk assessment for nongenotoxic carcinogens and tumor promoters	14.2	0	1
Evolution of environmental epidemiologic risk assessment	14.2	0	1
Biomarkers of exposure and effect-interpretation in human risk assessment	14.2	0	1
Risk Assessment Principle for Engineered Nanotechnology in Food and Drug	14.2	0	1
Risk Assessment of Occupational Exposure to Crystalline Silica in Small Foundries in Pakdasht, Iran	14.2	0	1
Real-time safety risk assessment based on a real-time location system for hydropower construction sites	14.2	0	1
A cancer risk assessment of inner-city teenagers living in New York City and Los Angeles	14.2	0	1
Grouping and Read-Across Approaches for Risk Assessment of Nanomaterials	14.2	0	1
Estimation of the Disease Burden Attributable to 11 Risk Factors in Hubei Province, China: A Comparative Risk Assessment	14.2	0	1
Biomonitoring data for 2,4-dichlorophenoxyacetic acid in the United States and Canada: interpretation in a public health risk assessment context using Biomonitoring Equivalents	14.2	0	1
Exploring potential sources of differential vulnerability and susceptibility in risk from environmental hazards to expand the scope of risk assessment	14.2	0	1
Expanding the scope of risk assessment: methods of studying differential vulnerability and susceptibility	14.2	0	1
The implications of using a physiologically based pharmacokinetic (PBPK) model for pesticide risk assessment	14.2	0	1
Portable, non-invasive fall risk assessment in end stage renal disease patients on hemodialysis	14.2	0	1
Formaldehyde and leukemia: epidemiology, potential mechanisms, and implications for risk assessment	14.2	0	1
Formaldehyde carcinogenicity research: 30 years and counting for mode of action, epidemiology, and cancer risk assessment	14.2	0	1
The use of biomonitoring data in exposure and human health risk assessment: benzene case study	14.2	0	1
Cancer Risk Assessment in Welder's Under Different Exposure Scenarios	14.2	0	1
Using biomarkers to inform cumulative risk assessment	14.2	0	1
Improving pandemic influenza risk assessment	14.2	0	1
Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment	14.2	0	1
Radiation hormesis: historical perspective and implications for low-dose cancer risk assessment	14.2	0	1
Recent trend in risk assessment of formaldehyde exposures from indoor air	14.2	0	1
Reanalysis of the DEMS Nested Case‐Control Study of Lung Cancer and Diesel Exhaust: Suitability for Quantitative Risk Assessment	14.2	0	1
A ban on asbestos must be based on a comparative risk assessment	14.2	0	1
Growth-Enhanced Transgenic Coho Salmon (Oncorhynchus kisutch) Strains Have Varied Success in Simulated Streams: Implications for Risk Assessment	14.2	0	1
Emma Capital	14.2	0	1
Chemical analysis and risk assessment of diethyl phthalate in alcoholic beverages with special regard to unrecorded alcohol	14.2	0	1
Use-exposure relationships of pesticides for aquatic risk assessment	14.2	0	1
Toxicity testing in the 21 century: defining new risk assessment approaches based on perturbation of intracellular toxicity pathways	14.2	0	1
Text Mining for Literature Review and Knowledge Discovery in Cancer Risk Assessment and Research	14.2	0	1
Can physiological endpoints improve the sensitivity of assays with plants in the risk assessment of contaminated soils?	14.2	0	1
Personalized risk assessment of drug-related harm is associated with health outcomes	14.2	0	1
Development of an adverse drug reaction risk assessment score among hospitalized patients with chronic kidney disease	14.2	0	1
Systematic Omics Analysis Review (SOAR) tool to support risk assessment	14.2	0	1
Health risk assessment for air pollutants: alterations in lung and cardiac gene expression in mice exposed to Milano winter fine particulate matter (PM2.5)	14.2	0	1
Source Apportionment and Risk Assessment of Emerging Contaminants: An Approach of Pharmaco-Signature in Water Systems	14.2	0	1
Compromised NMDA/Glutamate Receptor Expression in Dopaminergic Neurons Impairs Instrumental Learning, But Not Pavlovian Goal Tracking or Sign Tracking	14.2	0	1
Ecological Risk Assessment of a Metal-Contaminated Area in the Tropics. Tier II: Detailed Assessment	14.2	0	1
Risk Assessment of Patients Undergoing Transfemoral Aortic Valve Implantation upon Admission for Post-Interventional Intensive Care and Surveillance: Implications on Short- and Midterm Outcomes	14.2	0	1
Macquarie Investment Management Australia Limited	14.2	0	1
Application of the analytic hierarchy approach to the risk assessment of Zika virus disease transmission in Guangdong Province, China	14.2	0	1
Lead intoxication in dogs: risk assessment of feeding dogs trimmings of lead-shot game	14.2	0	1
A Bayesian Belief Network for Murray Valley encephalitis virus risk assessment in Western Australia	14.2	0	1
Evaluation of surface water quality indices and ecological risk assessment for heavy metals in scrap yard neighbourhood	14.2	0	1
A Survey of 42 Semi-Volatile Organic Contaminants in Groundwater along the Grand Canal from Hangzhou to Beijing, East China	14.2	0	1
The PAediatric Risk Assessment (PARA) Mobile App to Reduce Postdischarge Child Mortality: Design, Usability, and Feasibility for Health Care Workers in Uganda	14.2	0	1
Human Health and Ecological Risk Assessment of 16 Polycyclic Aromatic Hydrocarbons in Drinking Source Water from a Large Mixed-Use Reservoir	14.2	0	1
Effect of health risk assessment and counselling on health behaviour and survival in older people: a pragmatic randomised trial	14.2	0	1
The Source, Spatial Distribution and Risk Assessment of Heavy Metals in Soil from the Pearl River Delta Based on the National Multi-Purpose Regional Geochemical Survey	14.2	0	1